Today: 16 April 2026
Dow futures tick up as delayed jobs report nears and an AI tax tool rattles Schwab

Dow futures tick up as delayed jobs report nears and an AI tax tool rattles Schwab

NEW YORK, Feb 11, 2026, 03:41 EST

  • U.S. stock futures ticked up, with investors eyeing the postponed January jobs figures and additional economic data expected this week.
  • The Dow managed to notch a fresh record on Tuesday, but both the S&P 500 and Nasdaq lost ground following subdued retail sales numbers.
  • Brokerage stocks took a hit on AI disruption worries. Robinhood and Astera Labs, meanwhile, saw action after posting earnings.

U.S. stock index futures ticked higher late Tuesday, with investors eyeing a postponed January jobs report set for release Wednesday and an inflation readout coming Friday. By 8:11 p.m. ET, S&P 500 futures were up 0.2% to 6,978.25, Nasdaq 100 futures climbed 0.3% to 25,291.75, and Dow futures edged 0.2% higher to 50,385.

This month’s jobs report isn’t the usual read. Nonfarm payrolls are forecast to rise by just 70,000 in January, with the unemployment rate sticking at 4.4%, after the government shutdown delayed the release. The report also folds in a benchmark revision—payroll figures get a shakeup from more complete data—and an update to the BLS “birth-death” model, which adjusts for job creation and losses from new business activity. KPMG’s Diane Swonk called the labor market “very much frozen.” Ron Hetrick at Lightcast didn’t sound much more upbeat, labeling conditions “anemic.” Reuters

Traders kicked off the week still betting on rate cuts later this year, but Tuesday brought no clear signals. The Dow notched its third consecutive record, inching up 0.10% to 50,188.14. The S&P 500 slipped 0.33% to 6,941.81, with the Nasdaq off 0.59% at 23,102.47. December’s retail sales missed estimates, coming in flat when a rise had been forecast. “Bad news is good news,” Janney Montgomery Scott’s Mark Luschini said of the market’s reaction. Reuters

Treasury yields pulled back after weaker consumer data, with markets watching jobs figures set for Wednesday for hints at possible rate cuts. The 10-year slipped to roughly 4.147%. Peter Cardillo at Spartan Capital figures “the jobs report may be weaker than expected.” Reuters

But the jobs report isn’t a one-way street, and it’s not just about the headline payrolls. Benchmark revisions or tweaks to the models can flip the story quickly. A wage shock? That has the power to jolt yields faster than the jobs number ever does.

AI disruption didn’t stay confined to one corner of the market on Tuesday—brokerages and wealth management firms got caught up too. Charles Schwab sank over 7%, while LPL Financial and Raymond James each slid more than 8%. The catalyst: startup Altruist launched AI-powered tax-planning tools that can read files like Form 1040 and spit out custom tax strategies. “Traders sell first and ask questions later,” said Dennis Dick from Stock Trader Network. Still, Citizens analysts see the business as “earned … through judgment, behavioral coaching and personalization.” Reuters

Robinhood shares dropped 6.3% in late trading after missing Wall Street’s fourth-quarter revenue forecasts, with crypto trading weaker than hoped. CFO Shiv Verma noted, “the active traders were still really active,” though the company flagged pressure from pricing. Gold subscribers—the paid tier offering an AI investing assistant—jumped 58% to 4.2 million. Reuters

Astera Labs, a chip-adjacent AI infrastructure player, fell after hours—even with a top- and bottom-line beat—as its outlook failed to spark enthusiasm in a market prone to knee-jerk reactions on AI spending. The company posted a record $270.6 million in fourth-quarter revenue and adjusted earnings of $0.58 a share. For the first quarter, Astera is guiding for revenue between $286 million and $297 million. CEO Jitendra Mohan told investors the results “highlight a stellar 2025.” Investing.com

Stock Market Today

  • Lean Hog Futures Edge Lower Ahead of Expiration with Mixed Pork Cutout Values
    April 16, 2026, 1:59 AM EDT. Lean hog futures fell Wednesday, with contracts losing 7 to 70 cents, while December rose 57 cents before Friday's expiration. The national average base hog negotiated price dropped 72 cents to $81.39. The CME Lean Hog Index declined 13 cents to $83.33 on December 9. USDA's pork cutout value was down 27 cents at $92.87 per hundredweight, with only butt and picnic cuts increasing. Wednesday's hog slaughter reached 487,000 head, slightly below last week but 35,040 head higher year-over-year. December 2024 hog futures closed at $83.50, up 57.5 cents; February 2025 fell 20 cents to $84.375; April 2025 slid 65 cents to $88.25. The market shows mixed signals amid declining pork values and steady slaughter rates.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 16.04.2026

16 April 2026
LIVEMarkets rolling coverageStarted: April 16, 2026, 12:00 AM EDTUpdated: April 16, 2026, 2:01 AM EDT Lean Hog Futures Edge Lower Ahead of Expiration with Mixed Pork Cutout Values April 16, 2026, 1:59 AM EDT. Lean hog futures fell Wednesday, with contracts losing 7 to 70 cents, while December rose 57 cents before Friday's expiration. The national average base hog negotiated price dropped 72 cents to $81.39. The CME Lean Hog Index declined 13 cents to $83.33 on December 9. USDA's pork cutout value was down 27 cents at $92.87 per hundredweight, with only butt and picnic cuts increasing. Wednesday's hog
Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
London Stock Exchange Group (LSEG) share price jumps on Elliott stake report as buyback debate flares up
Previous Story

London Stock Exchange Group (LSEG) share price jumps on Elliott stake report as buyback debate flares up

Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive
Next Story

Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive

Go toTop